RBRobert L. Burr

Robert L. Burr

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Robert L. Burr has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Rest-Activity Rhythm Fragmentation and Weaker Circadian Strength Are Associated With Cognitive Impairment in Survivors of Acute Respiratory Failure

    by Pei-Lin Yang, Naomi S. Chaytor, Robert L. Burr, Vishesh K. Kapur, Susan M. McCurry, Michael V. Vitiello, Catherine L. Hough, Elizabeth C. Parsons

    Background : Survivors of acute respiratory failure (ARF) experience long-term cognitive impairment and circadian rhythm disturbance after hospital discharge. Although prior studies in aging and neurodegenerative diseases indicate actigraphy-estimated rest-activity circadian rhythm disturbances are risk factors for cognitive impairment, it is unclear if this applies to ARF survivors. This study explored the relationships of actigraphy-estimated rest-activity circadian rhythms with cognitive functioning in ARF survivors at 3 months after discharge. Methods : 13 ARF survivors (mean age 51 years and 69% males) completed actigraphy and sleep diaries for 9 days, followed by at-home neuropsychological assessment. Principal component factor analysis created global cognition and circadian rhythm variables, and these first components were used to examine the global relationships between circadian rhythm and cognitive measure scores. Results : Global circadian function was associated with global cognition function in ARF survivors ( r = .70, p = .024) after adjusting for age, education, and premorbid cognition. Also, greater fragmented rest-activity circadian rhythm (estimated by intradaily variability, r = .85, p = .002), and weaker circadian strength (estimated by amplitude, r = .66, p = .039; relative strength, r = .70, p = .024; 24-h lag serial autocorrelation, r = .67, p = .035), were associated with global cognition and individual cognitive tests. Conclusions : These results suggest circadian rhythm disturbance is associated with poorer global cognition in ARF survivors. Future prospective research with larger samples is needed to confirm these results and increase understanding of the relationship between disrupted circadian rhythms and cognitive impairment among ARF survivors.


  • Tu1381: TRYPTOPHAN FUNCTIONAL CAPABILITY AND BIFIDOBACTERIUM ABUNDANCE AND THEIR RELATIONSHIP TO ANXIETY AND DEPRESSIVE SYMPTOMS IN WOMEN WITH AND WITHOUT IRRITABLE BOWEL SYNDROME

    by Miriam Levy, Anna M. Plantinga, Kendra Kamp, Li Juen Chen, Linda Yoo, Kevin Cain, Robert Burr, Robert J. Shulman, Margaret Heitkemper

  • Tu1565: RELATIONSHIP BETWEEN ESCHERICHIA/SHIGELLA AND ABDOMINAL PAIN AMONG WOMEN WITH IRRITABLE BOWEL SYNDROME

    by Linda Yoo, Kendra Kamp, Li Juen Chen, Kevin Cain, Robert Burr, Sik Yu So, Shyam Badu, Qinglong Wu, Tor C. Savidge, Robert J. Shulman, et al.


  • Open Access

    Stool and urine trefoil factor 3 levels: associations with symptoms, intestinal permeability, and microbial diversity in irritable bowel syndrome

    by M.M. Heitkemper, K.C. Cain, R.J. Shulman, R.L. Burr, C. Ko, E.B. Hollister, N. Callen, J. Zia, C.J. Han, M.E. Jarrett

    Previously we showed that urine trefoil factor 3 (TFF3) levels were higher in females with irritable bowel syndrome (IBS) compared to non-IBS females. To assess if TFF3 is associated with symptoms and/or reflect alterations in gastrointestinal permeability and gut microbiota in an IBS population, we correlated stool and urine TFF3 levels with IBS symptoms, intestinal permeability, stool microbial diversity and relative abundance of predominant bacterial families and genera. We also tested the relationship of stool TFF3 to urine TFF3, and compared results based on hormone contraception use. Samples were obtained from 93 females meeting Rome III IBS criteria and completing 4-week symptom diaries. TFF3 levels were measured by ELISA. Permeability was assessed with the urine lactulose/mannitol (L/M) ratio. Stool microbiota was assessed using 16S rRNA. Stool TFF3, but not urine TFF3, was associated positively with diarrhoea and loose stool consistency. Higher stool TFF3 was also associated with lower L/M ratio and microbial diversity. Of the 20 most abundant bacterial families Mogibacteriaceae and Christensenellaceae were inversely related to stool TFF3, with only Christensenellaceae remaining significant after multiple comparison adjustment. There were no significant relationships between stool or urine TFF3 levels and other symptoms, nor between stool and urine levels. In premenopausal females, urine TFF3 levels were higher in those reporting hormone contraception. Collectively these results suggest that higher stool TFF3 levels are associated with IBS symptoms (loose/diarrhoeal stools), lower gut permeability, and altered stool bacteria composition (decreased diversity and decreased Christensenellaceae), which further suggests that TFF3 may be an important marker of host-bacteria interaction.


  • Adherence to an Aerobic Exercise Intervention after an Implantable Cardioverter Defibrillator (ICD)

    by Cynthia M. Dougherty, Matilda N. Luttrell, Robert L. Burr, Misun Kim, William L. Haskell

    Background: Exercise adherence is an important element in achieving important exercise outcomes. The purpose of this study was to describe adherence in a home‐based aerobic exercise program following an implantable cardioverter defibrillator (ICD), determine effects of adherence on peakVO2, and outline reasons for nonadherence.Methods and Results: A single‐blind randomized control trial of home walking compared to usual care in 160 patients with an ICD for primary or secondary prevention was conducted. This report is on adherence in the exercise arm (N = 84). Home walking exercise consisted of 8 weeks of aerobic conditioning (60 minutes/day, 5 days/week) followed by 16 weeks of aerobic maintenance (150 minutes/week, 30 minutes/session) at 60–80% of heart rate reserve. Adherence was tracked using Polar heart rate (HR) monitors, pedometers, home exercise logs, and telephone follow‐up. Adherence was defined as performing at least 80% of prescribed exercise. For aerobic conditioning, there was a mean frequency of 3.81 walks/week, duration of 1,873 minutes walked, and 17.5% of exercise was in the target HR (THR) zone. For aerobic maintenance, there was a mean frequency of 2.4 walks/week, duration of 1,872 minutes/walked, and 8.7% of exercise was in the THR zone. Those who were 80% adherent achieved a 3.4 mL/kg/min (P = 0.03) improvement in peakVO2 over those who were 2. Exercise monitoring equipment encouraged adherence and conferred a sense of safety to exercise.